Aurinia Pharmaceuticals Inc. (AUPH) › Cash & EquivalentsAurinia Pharmaceuticals Inc. (AUPH) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2019: $306.02M2020: $272.35M2021: $231.64M2022: $94.09M2023: $48.76M2024: $83.40M2025: $80.16M$80.16M2019Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$80.16M-3.9%2024$83.40M+71.1%2023$48.76M-48.2%2022$94.09M-59.4%2021$231.64M-14.9%2020$272.35M-11.0%2019$306.02M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share